Caribou Biosciences (CRBU) Retained Earnings (2021 - 2026)
Caribou Biosciences (CRBU) reported Retained Earnings of -$23000.0 for Q1 2026, up 100.0% year-over-year from -$11500.3 in Q1 2025, and down 122.33% quarter-over-quarter from $103000.0 in Q4 2025.
Caribou Biosciences (CRBU) Retained Earnings (2021 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has 6 years of Retained Earnings data on file, last reported at -$23000.0 in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$23000.0, up 100.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$23000.0 (up 100.0% YoY), and the FY2025 annual result was $103000.0, down 59.61% from the prior year.
- Retained Earnings declined to -$23000.0 in Q1 2026 per CRBU's latest filing, from $103000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $255000.0 in Q4 2024 and troughed at -$570.0 million in Q3 2025.
- A 5-year average of -$220.5 million and a median of -$197.2 million in 2022 frame the typical range for Retained Earnings.
- On a YoY basis, Retained Earnings climbed as much as 100.09% in 2024 and fell as far as 46546.44% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$197.2 million in 2022, then plunged by 51.76% to -$299.3 million in 2023, then surged by 100.09% to $255000.0 in 2024, then plunged by 59.61% to $103000.0 in 2025, then slumped by 122.33% to -$23000.0 in 2026.
- Business Quant data shows CRBU's Retained Earnings at -$23000.0 in Q1 2026, $103000.0 in Q4 2025, and -$570.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Caribou Biosciences | 156.73 Mn | 39.11 Mn | - | -23,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23,000.00 |
| Dec 31, 2025 | 103,000.00 |
| Sep 30, 2025 | -570.03 Mn |
| Jun 30, 2025 | -542.50 Mn |
| Mar 31, 2025 | -488.38 Mn |
| Dec 31, 2024 | 255,000.00 |
| Sep 30, 2024 | -412.90 Mn |
| Jun 30, 2024 | -378.22 Mn |
| Mar 31, 2024 | -340.52 Mn |
| Dec 31, 2023 | -299.29 Mn |
| Sep 30, 2023 | -981,000.00 |
| Jun 30, 2023 | -254.80 Mn |
| Mar 31, 2023 | -730,000.00 |
| Dec 31, 2022 | -197.22 Mn |
| Sep 30, 2022 | -2.04 Mn |
| Jun 30, 2022 | -143.60 Mn |
| Mar 31, 2022 | -116.90 Mn |
| Dec 31, 2021 | -97.79 Mn |
| Sep 30, 2021 | -79.32 Mn |
| Jun 30, 2021 | -58.34 Mn |